Effect of Chili Pepper Extract on Weight and Fat Loss and Metabolism Increase

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE2

Total Enrollment

80 participants

Study Classification

INTERVENTIONAL

Study Start Date

2006-04-30

Study Completion Date

2007-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to test the safety and effectiveness of a purified extract of CH-19 Sweet, containing capsinoids.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Capsaicinoid Ingestion, Human Metabolism and Exercise

NCT02139852

Metabolism

WITHDRAWN

Capsaicinoid Ingestion, Human Metabolism and Exercise (Phase 2)

NCT02138630

Metabolism Exercise

WITHDRAWN NA

Effects of a Specific Spice on Energy Metabolism

NCT00841893

Healthy

COMPLETED NA

Physiologic Effect of Spices Ingestion

NCT02193438

Healthy

COMPLETED NA

The Acute Effects of Capsiate During Exercise

NCT00692601

Healthy

COMPLETED PHASE1

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Overweight Obesity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Oral ingestion of 6mg chili pepper extract

Group Type EXPERIMENTAL

Chronic consumption of chili pepper extract

Intervention Type DIETARY_SUPPLEMENT

6mg chili pepper extract per day in two divided doses (before the morning meal and before the evening meal) up to 12 weeks.

2

Oral ingestion of 0 mg chili pepper extract (matching placebo)

Group Type PLACEBO_COMPARATOR

Chronic consumption of matching placebo

Intervention Type DIETARY_SUPPLEMENT

0mg chili pepper extract (matching placebo) per day in two divided doses (before the morning meal and before the evening meal) up to 12 weeks.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Chronic consumption of chili pepper extract

6mg chili pepper extract per day in two divided doses (before the morning meal and before the evening meal) up to 12 weeks.

Intervention Type DIETARY_SUPPLEMENT

Chronic consumption of matching placebo

0mg chili pepper extract (matching placebo) per day in two divided doses (before the morning meal and before the evening meal) up to 12 weeks.

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Is overweight or obese but otherwise generally healthy who interested in losing weight
* BMI of 25 to 35 kg/m2
* Waist/hip ratio of 0.9 or more for male and 0.85 for female.

Exclusion Criteria

* Type 1 or 2 diabetes mellitus
* cardiovascular disease (other than mild, controlled hypertension or dislidemia)
* On a weight-loss program within six months

Minimum Eligible Age

25 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes